Skip to main content

Jason Alger

Equibles does not estimate personal net worth.

Get an email with a short summary when Health Catalyst, Inc. publishes a filing, an earnings call transcript or a press release.

Get HCAT alerts

About Jason Alger

Jason Alger is recorded as Chief Accounting Officer and CFO at Health Catalyst, Inc. (HCAT). The newest filing on record that lists Jason Alger as CFO at Health Catalyst, Inc. (HCAT) is dated June 3, 2026. The newest filing on record that lists Jason Alger as Chief Accounting Officer at Health Catalyst, Inc. (HCAT) is dated April 27, 2023. Health Catalyst, Inc. reported in an 8-K filed February 22, 2024 that Jason Alger was appointed Chief Financial Officer, effective March 1, 2024. The proxy statement of Health Catalyst, Inc. reports total compensation of $1,988,472 for Jason Alger in fiscal 2025, including a base salary of $353,125. Disclosed compensation is on record for 3 fiscal years. Jason Alger has spoken on 7 earnings calls and 4 other investor events across 1 company, most recently for Health Catalyst, Inc. on June 24, 2026. Health Catalyst, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at Health Catalyst, Inc. includes Ben Albert (CEO), Simeon Kohl (CEO and Board Member), John A. (Jack) Kane (Chairman) and 7 others.

“On February 22, 2024, the Company announced that Jason Alger, age 40, the Company's Chief Accounting Officer and principal accounting officer, will assume the role of Chief Financial Officer and principal financial officer of the Company, effective March 1, 2024.”
Health Catalyst, Inc. Form 8-K, filed February 22, 2024 · Read the filing

Jason Alger on recent calls

“We exceeded our guidance on both revenue and adjusted EBITDA. We are reporting strong Q1 bookings, which gives us confidence our commercial simplification work is gaining traction, and our cost discipline continues to show up in the numbers.”
CFO, Truist Securities Healthcare Disruptors & Digital Health Conference ·
“We exceeded our guidance on both revenue and adjusted EBITDA. We are reporting strong Q1 bookings, which gives us confidence our commercial simplification work is gaining traction, and our cost discipline continues to show up in the numbers.”
CFO, Health Catalyst, Inc. Q1 FY2026 Earnings Call ·
“We exceeded our guidance on both revenue and adjusted EBITDA. We are reporting strong Q1 bookings, which gives us confidence our commercial simplification work is gaining traction, and our cost discipline continues to show up in the numbers.”
CFO, Citi’s 2025 Global Healthcare Conference ·
“We exceeded our guidance on both revenue and adjusted EBITDA. We are reporting strong Q1 bookings, which gives us confidence our commercial simplification work is gaining traction, and our cost discipline continues to show up in the numbers.”
CFO, 8th Annual Evercore Healthcare Conference ·
“We exceeded our guidance on both revenue and adjusted EBITDA. We are reporting strong Q1 bookings, which gives us confidence our commercial simplification work is gaining traction, and our cost discipline continues to show up in the numbers.”
CFO, Stephens Annual Investment Conference ·

Affiliation history

Company network

Leadership on record at Health Catalyst, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Health Catalyst, Inc. (HCAT) $353,125 $1,988,472
2024 Health Catalyst, Inc. (HCAT) $338,333 $1,287,155
2023 Health Catalyst, Inc. (HCAT) $271,250 $823,615

Recent activity